Google Invests In European Biotech Fund

June 26, 2017
The $300 million fund will back public and private firms in late stage drug development.

Continuing its foray into global medical research and a potential long-term healthcare business, Google invests alongside Novartis in a $300 million European biotech fund, according to an article from Reuters. The fund is run by life sciences investment firm Medicxi and will reportedly back public and private firms in late stage drug development. 

Google’s recent healthcare moves include deals between Verily, a unit of Google parent Alphabet, and GlaxoSmithKline, Johnson & Johnson and others involving technologies ranging from diabetes management to robotic surgery, according to Reuters. Former U.S. Food and Drug Administration head Robert Califf has also joined the Verily team. Other initiatives reportedly involve treatments to fight aging by Calico, another Google business, and investment in dozens of U.S. healthcare start-ups.  According to Reuters, Verily will appoint two members to the new fund’s scientific advisory board.

Read the entire article here.

Sponsored Recommendations

Heat Recovery: Turning Air Compressors into an Energy Source

More than just providing plant air, they're also a useful source of heat, energy savings, and sustainable operations.

Controls for Industrial Compressed Air Systems

Master controllers leverage the advantages of each type of compressor control and take air system operations and efficiency to new heights.

Discover Your Savings Potential with the Kaeser Toolbox

Discover your compressed air station savings potential today with our toolbox full of calculators that will help you determine how you can optimize your system!

The Art of Dryer Sizing

Read how to size compressed air dryers with these tips and simple calculations and correction factors from air system specialists.